Of interest, expression of SAA has been detected in non-hepatic tissues and its over-expression has been implicated in chronic inflammation and IR development in peripheral tissues in obesity and type 2 diabetes [14–17]. Here, SAA1 is linked to obesity due to melanocortin 4 receptor deficiency.